506 related articles for article (PubMed ID: 14645428)
21. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
[TBL] [Abstract][Full Text] [Related]
22. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
[TBL] [Abstract][Full Text] [Related]
23. [Bone marrow transplantation versus maintenance chemotherapy for adult acute leukemia in first remission].
Suzuki R; Iida H; Taji H; Murata M; Sugihara T; Minami S; Kodera Y
Rinsho Ketsueki; 1996 Dec; 37(12):1362-70. PubMed ID: 8997123
[TBL] [Abstract][Full Text] [Related]
24. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
25. Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remission.
Ferrara F; Morabito F; Latagliata R; Martino B; Annunziata M; Oliva E; Schiavone EM; Pollio F; Palmieri S; Gianfaldoni G; Leoni F
Haematologica; 2001 Aug; 86(8):814-20. PubMed ID: 11522537
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO).
Saarinen UM; Mellander L; Nysom K; Ringden O; Schroeder H; Glomstein A; Gustafsson G
Bone Marrow Transplant; 1996 Mar; 17(3):357-63. PubMed ID: 8704687
[TBL] [Abstract][Full Text] [Related]
27. Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience.
Jourdan E; Boiron JM; Dastugue N; Vey N; Marit G; Rigal-Huguet F; Molina L; Fegueux N; Pigneux A; Recher C; Rossi JF; Attal M; Sotto JJ; Maraninchi D; Reiffers J; Bardou VJ; Esterni B; Blaise D
J Clin Oncol; 2005 Oct; 23(30):7676-84. PubMed ID: 16186596
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sharathkumar A; Saunders EF; Dror Y; Grant R; Greenberg M; Weitzman S; Chan H; Calderwood S; Freedman MH; Doyle J
Bone Marrow Transplant; 2004 Jan; 33(1):39-45. PubMed ID: 14566329
[TBL] [Abstract][Full Text] [Related]
29. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Gorin NC; Meloni G; Blaise D; Reiffers J; Carlson K; Fouillard L; Frassoni F
Bone Marrow Transplant; 2000 May; 25(10):1053-8. PubMed ID: 10828865
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center.
Gassas A; Ishaqi MK; Afzal S; Finkelstein-Shechter T; Dupuis A; Doyle J
Bone Marrow Transplant; 2008 Jun; 41(11):941-5. PubMed ID: 18264141
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic value of early treatment response in children with acute myeloid leukemia].
Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies--matched pair analysis].
Creutzig U; Bender-Götze C; Klingebiel T; Ebell W; Friedrich W; Stollmann-Gibbels B; Schmidt H; Suttorp M; Gratwohl A; Heyen P
Klin Padiatr; 1992; 204(4):246-52. PubMed ID: 1518260
[TBL] [Abstract][Full Text] [Related]
33. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.
Schlenk RF; Benner A; Krauter J; Büchner T; Sauerland C; Ehninger G; Schaich M; Mohr B; Niederwieser D; Krahl R; Pasold R; Döhner K; Ganser A; Döhner H; Heil G
J Clin Oncol; 2004 Sep; 22(18):3741-50. PubMed ID: 15289486
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
[TBL] [Abstract][Full Text] [Related]
36. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J
Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368
[TBL] [Abstract][Full Text] [Related]
37. [Prognosis, treatment completion, and complications in nonresponders in the study AML-BFM87].
Kallage V; Müller JE; Zimmermann M; Beck JD; Ritter J; Creutzig U
Klin Padiatr; 1999; 211(4):250-9. PubMed ID: 10472559
[TBL] [Abstract][Full Text] [Related]
38. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
Ball ED; Wilson J; Phelps V; Neudorf S
Bone Marrow Transplant; 2000 Apr; 25(8):823-9. PubMed ID: 10808202
[TBL] [Abstract][Full Text] [Related]
39. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
[TBL] [Abstract][Full Text] [Related]
40. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.
De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C
Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
